TBX3 and metabolic dysfunction-associated steatotic liver disease: While selective insulin resistance seen in diabetic patients is a major driver of fatty liver disease, complete loss of hepatic insulin signaling is known to ameliorate MASLD (21), so we asked whether Tbx3 might induce complete insulin resistance.